AstraZeneca Diabetes Drug Onglyza May be Associated with Increased Rate of Death
Onglyza Rate Of Death. After a preliminary review of data, the Food and Drug Administration (FDA) reports that AstraZeneca’s diabetes drug Onglyza (saxagliptin) may be associated with an increased rate [...]